Shenzhen New Industries Biomedical Engineering Co., Ltd. (SHE:300832)

Market Cap	47.93B
Revenue (ttm)	4.55B
Net Income (ttm)	1.65B
Shares Out	785.72M
EPS (ttm)	2.10
PE Ratio	29.05
Forward PE	26.30
Dividend	1.30 (2.13%)
Ex-Dividend Date	May 28, 2025

Volume	1,965,100
Average Volume	3,127,904
Open	61.21
Previous Close	61.00
Day's Range	60.30 - 61.75
52-Week Range	49.01 - 72.90
Beta	-0.42
RSI	39.31
Earnings Date	Oct 29, 2025

About SHE:300832

Shenzhen New Industries Biomedical Engineering Co., Ltd., engages in the research, development, production, and sale of clinical laboratory instruments and in vitro diagnostic reagents to hospitals in China and internationally. It offers immunoassay machine, biochemistry/electrolyte, integrated system, lab automation, molecular diagnostics, and rapid test solutions. The company was founded in 1995 and is based in Shenzhen, China.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1995
• Employees: 2,841
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300832

Financial Performance

In 2024, SHE:300832's revenue was 4.54 billion, an increase of 15.41% compared to the previous year's 3.93 billion. Earnings were 1.83 billion, an increase of 10.57%.